Candriam SCA
ORIC icon

Candriam SCA’s Oric Pharmaceuticals ORIC Stock Holding History

Candriam SCA’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.7M Sell
788,125
-391,643
-33% -$4.88M 0.05% 266
2026
Q2 		$12.8M Buy
1,179,768
+605,683
+106% +$5.49M 0.06% 255
2026
Q1 		$7.27M Buy
+574,085
New +$6.52M 0.04% 333

Other funds holding ORIC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

Candriam SCA's ORIC Position: Q3 2026 in Review

Candriam SCA reduced its Oric Pharmaceuticals (ORIC) stake by 33% in Q3 2026, selling an estimated $4.88M and leaving 788,125 shares worth $10.7M. The position accounts for 0.05% of the portfolio, ranked #266.

Candriam SCA first reported a position in ORIC in Q1 2026 and has held it in 3 quarters since. The position peaked at $12.8M in Q2 2026. 35 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Candriam SCA held 788,125 shares of Oric Pharmaceuticals worth $10.7M as of Q3 2026.
  • Candriam SCA sold 391,643 Oric Pharmaceuticals shares in Q3 2026, an estimated $4.88M.
  • Oric Pharmaceuticals made up 0.05% of Candriam SCA's portfolio in Q3 2026, its #266 holding.
  • Candriam SCA first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Candriam SCA's Oric Pharmaceuticals position peaked at $12.8M in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Candriam SCA's 13F filing for Q3 2026, filed 3 Nov 2026.